Researchers Engineer Pancreatic Cell Transplants to Evade Immune Response

In a finding that could significantly influence the way type 1 diabetes is treated, researchers at Albert Einstein College of Medicine of Yeshiva University have developed a technique for transplanting insulin-producing pancreatic cells that causes only a minimal immune response in recipients.

Read the whole article on Newswise - Scinews

More from Newswise - Scinews